HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
about
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
@en
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
@nl
type
label
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
@en
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
@nl
prefLabel
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
@en
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
@nl
P2093
P2860
P50
P1476
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
@en
P2093
Carmen Garrido
Catherine Lacout
Fernando Rodrigues-Lima
Franck Vitte
François Girodon
Gaétan Chanteloup
Jean Noël Bastie
Laurent Martin
Lucia Kubovcakova
Margaux Sevin
P2860
P2888
P356
10.1038/S41467-018-03627-9
P407
P577
2018-04-12T00:00:00Z
P6179
1103149429